Ignite Creation Date:
2025-12-24 @ 10:10 PM
Ignite Modification Date:
2026-01-02 @ 3:34 PM
Study NCT ID:
NCT04159935
Status:
TERMINATED
Last Update Posted:
2023-05-16
First Post:
2019-11-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Investigating iLux Efficacy in Contact Lens Wearers With Evaporative Dry Eye Disease
Sponsor:
University of Waterloo
Organization:
Study Overview
Official Title:
Investigating iLux Efficacy in Contact Lens Wearers With Evaporative Dry Eye Disease
Status:
TERMINATED
Status Verified Date:
2023-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Cancelled due to COVID-19
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SHEEPDOG
Brief Summary:
The purpose of this clinical trial is to investigate the efficacy of a single iLux® treatment in symptomatic CL wearers who have DED (according to the TFOS DEWS II diagnostic criteria), of the evaporative dry eye disease subtype (EDE).
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?: